(Q33385676)

26 July 2017

Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles (English)

1 reference

26 July 2017

Simone Diermeier-Daucher

4

object named as

S Diermeier-Daucher

1 reference

26 July 2017

G Schmitz

6

1 reference

26 July 2017

10

R Knüchel

1 reference

26 July 2017

11

G Brockhoff

1 reference

26 July 2017

M Plander

1

1 reference

26 July 2017

S Seegers

2

1 reference

26 July 2017

P Ugocsai

3

1 reference

26 July 2017

J Iványi

5

1 reference

26 July 2017

F Hofstädter

7

1 reference

26 July 2017

S Schwarz

8

1 reference

26 July 2017

E Orsó

9

1 reference

26 July 2017

6 August 2009

1 reference

26 July 2017

1 reference

26 July 2017

23

1 reference

26 July 2017

11

1 reference

26 July 2017

2118-2128

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2009.145

26 July 2017

0 references

cites work

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

The role of IRF-4 in B and T cell activation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Optimization of three- and four-color multiparameter DNA analysis in lymphoma specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Interleukin-6 is a growth factor for nonmalignant human plasmablasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Different binding mechanisms of myeloid leukemic cells to adhesion molecules on bone marrow stromal fibroblasts induced by TNF-alpha and IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: a new therapeutic option

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

Chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27/CD70 interaction

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Plasticity of marrow-derived stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Simultaneous evaluation of T- and B-cell clonality, t(11;14) and t(14;18), in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis: a method for the rapid molecular diagnosis of

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.145

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.145

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference